Dactinomycin Clinical Trials

A listing of Dactinomycin medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5 clinical trials
Dominantly Inherited Alzheimer Network (DIAN)

The overall purpose of this research is to understand the changes that occur in dominantly inherited Alzheimer disease.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Indiana Alzheimer Disease Core Center

The purpose of this program is to identify, evaluate, study, and follow persons who have Alzheimer?s disease, those who have other disorders of memory and thinking, and older individuals who have normal memory and thinking.

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Phase 1 Study to Evaluate the Safety and Tolerability of a Study Drug in Subjects with Early Alzheimer's Disease (AD)

This study will test the safety and tolerability of an experimental study drug that may delay Alzheimer’s disease (AD) onset or slow the progression of possible AD-related damage due to protein build-up in the brain.   Methods include measuring the amount of study drug and drug-related material in the cerebrospinal fluid …

  • 0 views
  • 19 Feb, 2024
  • 1 location
DEcisions about Cancer screening in Alzheimer's Disease (DECAD)

The purpose of this study is to gain an understanding about the use of educational pamphlets by caregivers of women with dementia. This study will randomly assign caregivers to receive one of two different educational pamphlets and is designed to gather information on how caregivers make health care decisions for …

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Randomized Phase 3 Study of Vincristine Dactinomycin Cyclophosphamide (VAC) Alternating with Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI Torisel NSC# 683864 IND# 122782) in Patients with Intermediate Risk (IR) Rhabdomyosarcoma (RMS)

The purpose of this study is to compare the event-free survival of patients with IR RMS treated with surgery, radiotherapy and VAC alternating with VI (VAC/VI) to that of patients treated with surgery, radiotherapy and VAC/VI plus temsirolimus (TORI).

  • 0 views
  • 19 Feb, 2024
  • 1 location